Clinical data | |
---|---|
ATC code |
|
Identifiers | |
|
|
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
ECHA InfoCard | 100.220.595 |
Chemical and physical data | |
Formula | C8H14N2O |
Molar mass | 154.21 g/mol |
3D model (Jmol) | |
|
Milameline (CI-979, PD-129,409, RU-35,926) is a non-selective muscarinic acetylcholine receptor partial agonist with cognition-acting properties that was being investigated for the treatment of Alzheimer's disease, but produced poor results in clinical trials and was subsequently discontinued.